Tasly Pharmaceutical Group Co., Ltd (600535.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 22.51B |
| Enterprise Value | 22.56B |
| P/E Ratio | 17.04 |
| PEG Ratio | 1.58 |
| Price/Sales Ratio | 2.61 |
| Price/Book Ratio | 1.62 |
| Enterprise/Revenue | 2.53 |
| Enterprise/EBITDA | 11.17 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.19 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 8.24B |
| Revenue/Share | 5.35 |
| Gross Profit | 5.51B |
| EBITDA | 1.84B |
| Net Income | 1.11B |
| Diluted EPS | 0.74 |
Balance Sheet
| Total Cash | 3.7B |
| Total Cash/Share | 2.48 |
| Total Debt | 283.56M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 4.86 |
| Book Value Per Share | 8.73 |
Price History
| 52-Week Change | -10.1 |
| 52-Week High | 16.24 |
| 52-Week Low | 12.9 |
| Moving Average 50 Days | 14.08 |
| Moving Average 200 Days | 14.48 |
Statistics
| Average Volume | 13.05M |
| Shares Outstanding | 1.49B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.34 |
| Trailing Annual Dividend Yield | 2.43 |
| Payout Ratio | 0.38 |
| Last Split Factor | 7:5 |
| Last Split Date | June 05, 2018 |
AD
